論文（欧文）
2007年
|
1. Teramukai S, Ochiai K, Tada H, Fukushima M. PIEPOC: A new prognostic index for advanced epithelial ovarian cancer - Japan
Multinational Trial Organization OC01-01. J Clin Oncol 2007;25:3302-3306.
2. Teramukai S, Ochiai K, Tada H, Fukushima M. Reply to “Validation of a new prognostic index for advanced epithelial ovarian cancer:
results from its application to a UK-based cohort”. J Clin Oncol 2007;25:5670-5671.
3. Tada H, Matsui S, Kawahara M, Hosoe S, Hamada C, Fukushima M. Efficacy, toxicity and cost analysis for non-platinum triplet
(gemcitabine and vinorelbine followed by docetaxel) vs. platinum-based chemotherapy in IIIB / IV non-small cell lung cancer: Single
institution experience. Euro J Cancer Care 2007; June 11.
4. Nishimura T, Mohri K, Tada H, Yamada J, Suzumura M, Fukushima M. Microtesla extremely low frequency magnetic fields may ameliorate
hypertension. Georgian Medical News 2007;9:30-34.
5. Nishimura T, Tada H, Teraguchi Y, Guo X, Teramukai S, Fukushima M, Ohara T. Anti-aging effect of La-healer exercise. J Res Educ
Indian Med 2007;13:19-30.
6. Zhou B, Teramukai S, Fukushima M. Prevention and treatment of dementia or Alzheimer’s disease by statins: a meta-analysis. Dement
Geriatr Cogn Disord 2007;23:194-201.
7. Kojima S, Zhou B, Teramukai S, Hara A, Kosaka N, Matsuo Y, Suzuki H, Torigoe S, Suzuki T, Uno K, Fukushima M. Cancer screening of
healthy volunteers using whole-body 18F-FDG-PET scans: The Nishidai clinic study. Eur J Cancer 2007;43:1842-1848.
8. Matsui S, Ito M, Nishiyama H, Uno H, Kotani H, Watanabe J, Guilford P, Reeve A, Fukushima M, Ogawa O. Genomic characterization of
multiple clinical phenotypes of cancer using multivariate linear regression models. Bioinformatics 2007;23:732-738.
9. Tanaka K, Uemoto S, Egawa H, Takada Y, Ozawa K, Teramukai S, Kasahara M, Ogawa K, Ono M, Sato H, Takai K, Fukushima M, Inaba K.
Cytotoxic T cell-mediated defense against infections in human liver transplant recipients. Liver Transplant 2007;13:287-293.
10. Egawa H, Uemoto S, Takada Y, Ozawa K, Teramukai S, Haga H, Kasahara M, Ogawa K, Sato H, Ono M, Takai K, Fukushima M, Inaba K, Tanaka
K. Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver
transplantation in humans. Liver Transplant 2007;13;1262-1271.
11. Ueno M, Kiba T, Nishimura T, Kitano T, Yanagihara K, Yoshikawa K, Ishiguro H, Teramukai S, Fukushima M, Kato H, Inamoto T. Changes
in survival during the past two decades for breast cancer at the Kyoto University Hospital. Euro J Surg Oncol 2007;33:696-699.
12. Kanai M, Matsumoto S, Nishimura T, Shimada Y, Watanabe G, Kitano T, Misawa A, Ishiguro H, Yoshikawa S, Yanagihara K, Teramukai S,
Mitsumori M, Chiba T, Sakai Y, Fukushima M. Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin
combination therapy as a second-line regimen for advanced esophageal cancer. Int J Clin Oncol 2007;12:224-227.
13. Kitano T, Tada H, Nishimura T, Teramukai S, Kanai M, Nishimura T, Misawa M, Yoshikawa K, Yasuda H, Ishiguro H, Matsumoto S,
Yanagihara K, Fukushima M. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy. Int J
Hematol 2007;86:37-41.
14. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. Predictive value of chemotherapy-induced neutropenia for the
efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma. Brit J Cancer 2007;97:37-42.
15. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. Analysis of risk factors for severe adverse effects of oral
5-fluorouracil S-1 in patients with advanced gastric cancer. Gastric Cancer 2007;10:129-134.
16. Satoh S, Kawashima K, Matsumoto S, Hasegawa S, Okabe H, Nomura A, Yoshibayashi H, Watanabe G, Nagayama S, Fukushima M, Sakai Y.
Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer. Chemotherapy 2007;53:226-232.
17. Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y,
Depaoli AM, Fukushima M, Nakao K. Efficacy and safety of leptin-replacement therapy and possible mechanisma of leptin actions in
patients with generalized lipodystrophy. J Clin Endocrinol Metab 2007;92:532-541.
18. Hosoi H, Teramukai S, Matsumoto Y, Tsuchiya K, Iehara T, Hara J, Mitsui T, Kaneko M, Hatae Y, Hayashi Y, Mabuchi O, Adachi N,
Morikawa Y, Nishimura S, Kumagai M, Takamatsu H, Sawada T, Sugimoto T. A review of 331 rhabdomyosarcoma cases in patients treated
between 1991 and 2002 in Japan. Int J Clin Oncol 2007;12:137-145.
19. Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, Saji Y, Inui K, Hashida T, Yokoyama S, Onodera R, Ikeda T, Fukushima
M, Komeda M. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic
fibroblast growth factor using biodegradable gelatin hydrogel-An initial report of the phase I-IIa study-. Circ J 2007;71:1181-
1186.
20. Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Efficacy of adjuvant immunochemotherapy with polysaccharide K for
patients with curatively resected gastric cancer. Cancer Immunol Immunother 2007;56:905-911.
21. Zohar S, Teramukai S, Zhou Y. Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: a tutorial.
Contemp Clin Trials 2007, Dec 4.
22. Kitawaki T, Kadowaki N, Kondo T, Ishikawa T, Ichinohe T, Teramukai S, Fukushima M, Kasai Y, Maekawa T, Uchiyama T. Potential of
dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole
limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia. Am J Hematol 2007, Dec 14.
|
2006年
|
1. Teramukai S, Nishiyama H, Matsui Y, Ogawa O, Fukushima M. Evaluation for surrogacy of end points by using data from observational
studies: Tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer. Clin Cancer Res 2006;12:139-143.
2. Akamizu T, Murayama T, Teramukai S, Miura K, Bando I, Irako T, Iwakura H, Ariyasu H, Hosoda H, Tada H, Matsuyama A, Kojima S, Wada T,
Wakatsuki Y, Matsubayashi K, Kawakita T, Shimizu A, Fukushima M, Yokode M, Kangawa K. Plasma ghrelin levels in healthy elderly volunteers:
the levels of acylated ghrelin in elderly females correlate positively with serum IGF-1 levels and bowel movement frequency and negatively
with systolic blood pressure. J Endocrinol 2006;188:333-344.
3. Tanaka K, Ozawa K, Teramukai S, Takada Y, Egawa H, Kaihara S, Fujimoto Y, Ogura Y, Kasahara M, Ono M, Sato H, Takai K, Fukushima M, Minato
N. Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome. Liver
Transplant 2006;12:792-800.
4. Nishimura T, Tada H, Nakagawa M, Teramukai S, Matsui S, Fukushima M. Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures. Pharmacy Practice 2006;4:168-178.
5. Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K,
Doi E, Teramukai S, Fukushima M.. Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the
literature. Oncology 2006;70:358-365.
6. Satoh S, Hasegawa S, Ozaki N, Okabe H, Watanabe G, Nagayama S, Fukushima M, Takabayashi Y, Sakai Y. Prospective analysis of 45 consecutive
patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination. Gastric Cancer 2006;9:129-
135.
7. Kim I-D, Azuma T, Ido A, Moriuchi A, Numata M, Teramukai S, Okamoto J, Tsutsumi S, Tanaka K, Tsubouchi H. Navigator-echo-based MR provides
high-resolution images and precise volumetry of swine livers without breath holding or injection of contrast media. Liver Transplant
2006;12:72-77.
8. Hatano E, Ikai I, Higashi T, Teramukai S, Torizuka T, Saga T, Fujii H, Shimahara Y. Preoperative positron emission tomography with
Fluorine-18- Fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg
2006;30:1736-1741.
9. Kojima A, Ohno-Matsui K Teramukai S, Ishihara Y, Shimada N, Yoshida T, Sugamoto Y, Tokoro T, Machizuki M. Estimation of visual outcome
without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol
2006;244:1474-1479.
|
2005年
|
1. Matsui S, Sadaike T, Hamada C, Fukushima M. Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: An updated analysis of
incubation time. Neuroepidemiology 2005;24:22-25.
2. Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Oshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. The current status of
perioperative chemotherapy for invasive bladder cancer: A multiinstitutional retrospective study in Japan. Int J Clin Oncol 2005;
10:133-138.
3. Karita M, Teramukai S, Matsumoto S, Shibata H. Intracellular VacA is a valuable marker to predict whether Helicobacter pylori induces
progressive atrophic gastritis that is associated with the development of gastric cancer. Digest Dis Sci 2005;50:56-64.
4. Tanaka T, Iehara T, Sugimoto T, Hamasaki M, Teramukai S, Tsuchida Y. Kaneko M, Sawada T. Diversity in neuroblastomas and discrimination
of the risk to progress. Cancer Lett 2005 228:267-270.
|
2004年
|
1. Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Oshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. Clinical outcome of
a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during
1990-2000 in Japan. Eur Urol 2004;45:176-181.
2. Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, Tada H, Miura K, Shimizu A, Fukushima M, Yokode M, Tanaka K, Kangawa
K. Pharmacokinetics, safety, endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol
2004;150:447-455.
3. Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J. Individual patient-level and study-level meta-analysis for investigating modifiers of
treatment effect. Jpn J Clin Oncol 2004;34:717-721.
4. Kojima A, Ohno-Matsui K, Teramukai S, Yoshida T, Ishihara Y, Kobayashi K, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M.
Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia. Graefes Arch
Clin Exp Ophthalmol 2004;242:114-119.
5. Karita M, Noriyasu A, Teramukai S, Matsumoto S. Atrophic progression induced by H. pylori infection is correlated with a changing
pepsinogen I value and associated with the development of gastric cancer. Digest Dis Sci 2004;49:1615-1620.
6. Kato J, Sakamoto J, Teramukai S, Kojima H, Nakao A. A prospective within-patient comparison clinical trial on the effect of parenteral
cimetidine for improvement of fluid secretion and electrolyte balance in patients with short bowel syndrome. Hepato-gastroenterol
2004;51:1742-1746
|
2003年
|
1. Hamada C, Sadaike T, Fukushima M. Projection of Creutzfeldt-Jakob Disease frequency based on cadaveric dura transplantation in Japan.
Neuroepidemiology 2003;22:57-64.
2. Hosoe S, Komuta K, Shibata K, Harada H, Iwamoto Y, Ohsaki Y, Morioka Y, Origasa H, Fukushima M, Furuse K, Kawahara M. Gemcitabine and
vinorelbine followed by docetaxel in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial of
non-platinum sequential triplet combination chemotherapy (JMTO LC00-02). Br J Cancer 2003; 88:342-347.
3. Mohri K, Fukushima M. Milli-Gauss magnetic field triggering reliable self organization of water with long range ordered proton transport
through cyclotron resonance. IEEE Trans Mag 2003;36:3328-3330.
4. Fukui T, Rahman M, Hayashi K, Takeda K, Higaki J, Sato T, Fukushima M, Sakamoto J, Morita S, Ogihara T, Fukiyama K, Fujishima M, Saruta
T. Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods. Hypertens Res 2003;26:979-990.
5. Karita M, Teramukai S, Matsumoto S. Risk of Helicobacter pylori transmission from drinking well water is higher than that from infected
intrafamilial members in Japan. Dig Dis Sci 2003;48:1062-1067.
6. Karita M, Noriyasu A, Kosako E, Teramukai S, Matsumoto S. Relationship between pepsinogen I&II and H. pylori infection considered
with grade of atrophy and gastroduodenal diseases. Dig Dis Sci 2003;48:1839-1845.
|
2002年
|
1. Fukushima M, Mohri K, Kataoka T, Matsumoto M. Milli gauss pulsed magnetic field applied phosphate buffered saline solution
elevates intracellular Ca2+ level and stimulates phagocytic activity of human neutrophils. Trans Magn Soc Japan 2002;2:15-18.
2. Mohri K, Fukushima M. Gradual decreasing characteristics and temperature stability of electric resistivity in water triggered with milligauss AC field. IEEE Trans. Magn 2002;38:3353-3355.
3. Sakamoto J, Teramukai S. Data handling in cancer clinical trials − how we can minimize potential biases. Jpn J Clin Oncol
2002;32:1-2.
4. Teramukai S, RohanT, EguchiH, OdaT, ShinchiK, Kono S. Anthropometric and behavioral correlates of insulin-like growth factor I and
insulin growth binding protein 3 in middle-aged Japanese men. Am J Epidemiol 2002;156:344-348.
5. Sakamoto J, Teramukai S, Nakazato H, Sato Y, Uchino J, Taguchi T, Ryoma Y, Ohashi Y. Efficacy of adjuvant immunochemotherapy with
OK-432 for patients with curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials. J
Immunother 2002;25:405-412.
6. Teramukai S, RohanT, Lee KY, EguchiH, OdaT, Kono S. Insulin-like growth factor-I, binding protein-3 and colorectal adenomas in
Japanese men. Jpn J Cancer Res 2002;93:1187-1194.
7. Sakamoto J， Teramukai S, Ohashi Y. Design and methodology of meta-analysis to show the efficacy of OK-432. Anal Cancer Res Ther ： 2002;10:89-92．
|
|
|
|
